Vibrio vulnificus quorum-sensing molecule cyclo(Phe-Pro) inhibits RIG-I-mediated antiviral innate immunity

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Lee, Wooseong ^a   Lee, Seung Hoon ^a   Kim, Minwoo ^a   Moon, Jae Su ^a   Kim, Geon Woo ^a   Jung, Hae Gwang ^a   Kim, In Hwang ^b   Oh, Ji Eun ^c   Jung, Hi Eun ^c   Lee, Heung Kyu ^c   Ku, Keun Bon ^d   Ahn, Dae Gyun ^d   Kim, Seong Jun ^d   Kim, Kun Soo ^b   Oh, Jong Won ^a  

^a Yonsei University   (South Korea)

^b Sogang University   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d Korea Research Institute of Chemical Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATMOSPHERIC GENERAL CIRCULATION MODEL; BACTERIUM; HEPATITIS; IMMUNITY; INFLUENZA; PATTERN RECOGNITION; VIRUS;

HEPATITIS C VIRUS; NOROVIRUS; ORTHOMYXOVIRIDAE; VIBRIO VULNIFICUS;

BETA INTERFERON; CYCLO(PHENYLALANYL-PROLYL); CYCLOPEPTIDE; DDX58 PROTEIN, HUMAN; DIPEPTIDE; RETINOIC ACID INDUCIBLE PROTEIN I;

ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE MODEL; DRUG EFFECT; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LIVER CELL; MALE; METABOLISM; MICROBIOLOGY; MOUSE; NONOBESE DIABETIC MOUSE; PATHOGENICITY; PRIMARY CELL CULTURE; QUORUM SENSING; RAW 264.7 CELL LINE; RNA VIRUS; RNA VIRUS INFECTION; SCID MOUSE; SIGNAL TRANSDUCTION; SUPERINFECTION; TUMOR CELL LINE; VIBRIO VULNIFICUS; VIBRIOSIS;

ANIMALS; CELL LINE, TUMOR; DEAD BOX PROTEIN 58; DIPEPTIDES; DISEASE MODELS, ANIMAL; HEK293 CELLS; HEPATOCYTES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON-BETA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; PEPTIDES, CYCLIC; PRIMARY CELL CULTURE; QUORUM SENSING; RAW 264.7 CELLS; RNA VIRUS INFECTIONS; RNA VIRUSES; SIGNAL TRANSDUCTION; SUPERINFECTION; VIBRIO INFECTIONS; VIBRIO VULNIFICUS;

EID: 85045939424     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-04075-1     Document Type: Article

References (74)

1. Wu, B. et al. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol. Cell. 55, 511-523 (2014).
2. Hou, F. et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146, 448-461 (2011).
3. Schuster, M., Sexton, D. J., Diggle, S. P. & Greenberg, E. P. Acyl-homoserine lactone quorum sensing: from evolution to application. Annu. Rev. Microbiol. 67, 43-63 (2013).
4. Papenfort, K. & Bassler, B. L. Quorum sensing signal-response systems in Gram-negative bacteria. Nat. Rev. Microbiol. 14, 576-588 (2016).
5. Jones, M. K. & Oliver, J. D. Vibrio vulnificus: disease and pathogenesis. Infect. Immun. 77, 1723-1733 (2009).
6. Chao, W. N. et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am. J. Surg. 206, 32-39 (2013).
7. Chiang, S. R. & Chuang, Y. C. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J. Microbiol. Immunol. Infect. 36, 81-88 (2003).
8. Haq, S. M. & Dayal, H. H. Chronic liver disease and consumption of raw oysters: a potentially lethal combination-a review of Vibrio vulnificus septicemia. Am. J. Gastroenterol. 100, 1195-1199 (2005).
9. Horseman, M. A. & Surani, S. A comprehensive review of Vibrio vulnificus: an important cause of severe sepsis and skin and soft-tissue infection. Int. J. Infect. Dis. 15, e157-e166 (2011).
10. Anderson, M. et al. Fatal Vibrio vulnificus sepsis in vertically acquired hepatitis C. J. Pediatr. Gastroenterol. Nutr. 56, e32-e33 (2013).
11. Thrift, A. P., El-Serag, H. B. & Kanwal, F. Global epidemiology and burden of HCV infection and HCV-related disease. Nat. Rev. Gastroenterol. Hepatol. 14, 122-132 (2017).
12. Klose, K. E. Increased chatter: cyclic dipeptides as molecules of chemical communication in Vibrio spp. J. Bacteriol. 188, 2025-2026 (2006).
13. Park, D. K. et al. Cyclo(Phe-Pro) modulates the expression of ompU in Vibrio spp. J. Bacteriol. 188, 2214-2221 (2006).
14. Bellezza, I., Peirce, M. J. & Minelli, A. Cyclic dipeptides: from bugs to brain. Trends Mol. Med. 20, 551-558 (2014).
15. Minelli, A. et al. Cyclo(His-Pro) up-regulates heme oxygenase 1 via activation of Nrf2-ARE signalling. J. Neurochem. 111, 956-966 (2009).
16. Holden, M. T. et al. Quorum-sensing cross talk: isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other gram-negative bacteria. Mol. Microbiol. 33, 1254-1266 (1999).
17. Li, J., Wang, W., Xu, S. X., Magarvey, N. A. & McCormick, J. K. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl Acad. Sci. USA 108, 3360-3365 (2011).
18. Fitzgerald, K. A. et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496 (2003).
19. Takahasi, K. et al. X-ray crystal structure of IRF-3 and its functional implications. Nat. Struct. Biol. 10, 922-927 (2003).
20. Sun, Q. et al. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24, 633-642 (2006).
21. Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882-886 (2009).
22. Loo, Y. M. & Gale, M. Jr. Immune signaling by RIG-I-like receptors. Immunity 34, 680-692 (2011).
23. Kato, H. et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiationassociated gene 5. J. Exp. Med. 205, 1601-1610 (2008).
24. Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523-527 (2008).
25. Kell, A. et al. Pathogen-associated molecular pattern recognition of hepatitis C virus transmitted/founder variants by RIG-I is dependent on U-core length. J. Virol. 89, 11056-11068 (2015).
26. Baccala, R., Hoebe, K., Kono, D. H., Beutler, B. & Theofilopoulos, A. N. TLRdependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13, 543-551 (2007).
27. Kagan, J. C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955 (2006).
28. Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361-368 (2008).
29. Zhong, J. et al. Robust hepatitis C virus infection in vitro. Proc. Natl Acad. Sci. USA 102, 9294-9299 (2005).
30. Sumpter, R. Jr. et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I. J. Virol. 79, 2689-2699 (2005).
31. Gack, M. U. et al. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl Acad. Sci. USA 105, 16743-16748 (2008).
32. Loo, Y. M. et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J. Virol. 82, 335-345 (2008).
33. McCartney, S. A. et al. MDA-5 recognition of a murine norovirus. PLoS Pathog. 4, e1000108 (2008).
34. Jiang, F. et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479, 423-427 (2011).
35. Luo, D. et al. Structural insights into RNA recognition by RIG-I. Cell 147, 409-422 (2011).
36. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
37. Oshiumi, H., Miyashita, M., Matsumoto, M. & Seya, T. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS. Pathog. 9, e1003533 (2013).
38. Oshiumi, H. et al. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell. Host. Microbe 8, 496-509 (2010).
39. Liu, Y., Olagnier, D. & Lin, R. Host and viral modulation of RIG-I-mediated antiviral immunity. Front. Immunol. 7, 662 (2016).
40. Beckham, S. A. et al. Conformational rearrangements of RIG-I receptor on formation of a multiprotein:dsRNA assembly. Nucleic Acids Res. 41, 3436-3445 (2013).
41. Moon, J. S. et al. Inhibition of hepatitis C virus in mice by a small interfering RNA targeting a highly conserved sequence in viral IRES pseudoknot. PLoS ONE 11, e0146710 (2016).
42. Moon, J. S. et al. Inhibition of hepatitis C virus in mouse models by lipidoid nanoparticle-mediated systemic delivery of siRNA against PRK2. Nanomed.: Nanotechnol. Biol. Med. 12, 1489-1498 (2016).
43. Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140, 397-408 (2010).
44. Yoneyama, M. et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175, 2851-2858 (2005).
45. Yoneyama, M. et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5, 730-737 (2004).
46. Louber, J., Brunel, J., Uchikawa, E., Cusack, S. & Gerlier, D. Kinetic discrimination of self/non-self RNA by the ATPase activity of RIG-I and MDA5. BMC Biol. 13, 54 (2015).
47. Lassig, C. et al. ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA. eLife 4, e10859 (2015).
48. Anchisi, S., Guerra, J. & Garcin, D. RIG-I ATPase activity and discrimination of self-RNA versus non-self-RNA. mBio 6, e02349 (2015).
49. Jang, M. A. et al. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am. J. Hum. Genet. 96, 266-274 (2015).
50. Hor, L. I., Chang, Y. K., Chang, C. C., Lei, H. Y. & Ou, J. T. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol. Immunol. 44, 871-878 (2000).
51. Metwally, M. A., Zein, C. O. & Zein, N. N. Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am. J. Gastroenterol. 99, 286-291 (2004).
52. Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322-335 (2008).
53. Mencin, A., Kluwe, J. & Schwabe, R. F. Toll-like receptors as targets in chronic liver diseases. Gut 58, 704-720 (2009).
54. Hsueh, P. R. et al. Vibrio vulnificus in Taiwan. Emerg. Infect. Dis. 10, 1363-1368 (2004).
55. Gulig, P. A., Bourdage, K. L. & Starks, A. M. Molecular pathogenesis of Vibrio vulnificus. J. Microbiol. 43, 118-131 (2005).
56. Martins, M. B. C. I. Diketopiperazines: biological activity and synthesis. Tetrahedron 63, 9923-9932 (2007).
57. Cho, I. & Blaser, M. J. The human microbiome: at the interface of health and disease. Nat. Rev. Genet. 13, 260-270 (2012).
58. Vashist, S. et al. Molecular chaperone Hsp90 is a therapeutic target for noroviruses. J. Virol. 89, 6352-6363 (2015).
59. Wakita, T. et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11, 791-796 (2005).
60. Wu, Y., Liao, Q., Yang, R., Chen, X. & Chen, X. A novel luciferase and GFP dual reporter virus for rapid and convenient evaluation of hepatitis C virus replication. Virus Res. 155, 406-414 (2011).
61. Kim, S. E. et al. H-Ras is degraded by Wnt/beta-catenin signaling via beta- TrCP-mediated polyubiquitylation. J. Cell. Sci. 122, 842-848 (2009).
62. Lee, W. et al. The antiviral activity of poly-gamma-glutamic acid, a polypeptide secreted by Bacillus sp., through induction of CD14-dependent type I interferon responses. Biomaterials 34, 9700-9708 (2013).
63. Kim, G. W. et al. Hepatitis c virus core protein promotes miR-122 destabilization by inhibiting GLD-2. PLoS Pathog. 12, e1005714 (2016).
64. Wobus, C. E. et al. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2, e432 (2004).
65. Chattopadhyay, S. et al. Role of interferon regulatory factor 3-mediated apoptosis in the establishment and maintenance of persistent infection by Sendai virus. J. Virol. 87, 16-24 (2013).
66. Pena, J. et al. Sendai virus intra-host population dynamics and host immunocompetence influence viral virulence during in vivo passage. Virus Evol. 2, vew008 (2016).
67. Ichinohe, T., Lee, H. K., Ogura, Y., Flavell, R. & Iwasaki, A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206, 79-87 (2009).
68. Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat. Protoc. 3, 1101-1108 (2008).
69. McCormick, C. J., Challinor, L., Macdonald, A., Rowlands, D. J. & Harris, M. Introduction of replication-competent hepatitis C virus transcripts using a tetracycline-regulable baculovirus delivery system. J. Gen. Virol. 85, 429-439 (2004).
70. Li, K., Chen, Z., Kato, N., Gale, M. Jr. & Lemon, S. M. Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J. Biol. Chem. 280, 16739-16747 (2005).
71. Tsukiyama-Kohara, K. et al. Activation of the CKI-CDK-Rb-E2F pathway in full genome hepatitis C virus-expressing cells. J. Biol. Chem. 279, 14531-14541 (2004).
72. Christensen, J. E. et al. Fulminant lymphocytic choriomeningitis virusinduced inflammation of the CNS involves a cytokine-chemokine-cytokinechemokine cascade. J. Immunol. 182, 1079-1087 (2009).
73. Samali, A., Cai, J., Zhivotovsky, B., Jones, D. P. & Orrenius, S. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 18, 2040-2048 (1999).
74. Clark, K., Plater, L., Peggie, M. & Cohen, P. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation. J. Biol. Chem. 284, 14136-14146 (2009).